Biotek-snakken — Maj 2023
-
Vicore meddelar nya 36-veckorsresultat från AIR-studien som visar fortsatt sjukdomsstabilisering och ökad lungfunktion hos IPF-patienter
-
Stockholm, 19 maj 2023 - Vicore Pharma Holding AB (STO: VICO) (”Vicore”), ledande inom utveckling av en ny klass av läkemedel för att stoppa sjukdomsprogress och återställa funktion, offentliggör idag en uppdaterad interimsanalys av AIR fas 2a-studien med C21 vid behandling av idiopatisk lungfibros (IPF). Med 51 inkluderade patienter visar resultaten att C21 har potential att förändra behandlingen och återställa lungfunktionen vid IPF – en progressiv och idag obotlig sjukdom.
-
BioArctic : Marketing Authorization Application For Lecanemab Submitted In Great Britain https://www.proinvestor.com/investornyt/989216/bioarctic-marketing-authorization-application-for-lecanemab-submitted-in-great-britain
-
Icosavax Reports Positive Results From Phase 1 Trial Of IVX-A12 Against RSV & HMPV In Older Adults https://www.proinvestor.com/investornyt/989804/icosavax-reports-positive-results-from-phase-1-trial-of-ivx-a12-against-rsv-amp-hmpv-in-older-adults
-
FDA Approves Opiant's Nasal Spray 'Opvee' To Reverse Opioid Overdose https://www.proinvestor.com/investornyt/989789/fda-approves-opiants-nasal-spray-opvee-to-reverse-opioid-overdose
-
(2/2) EAM, HAVI, NOHAL, IDEX, ININ, IOX, MAS, MPCC, RISH, SALME, SDRL, UNIV, Euro-PMI, NO forbrukertillit, US PMI & gjeldstak
-
HC Wainwright & Co. Reiterates Dare Bioscience (DARE) Buy Recommendation https://www.proinvestor.com/investornyt/989851/hc-wainwright-amp-co-reiterates-dare-bioscience-dare-buy-recommendation
-
Goldman Sachs Maintains Krystal Biotech (KRYS) Buy Recommendation https://www.proinvestor.com/investornyt/989868/goldman-sachs-maintains-krystal-biotech-krys-buy-recommendation
-
B of A Securities Maintains Krystal Biotech (KRYS) Buy Recommendation https://www.proinvestor.com/investornyt/989870/b-of-a-securities-maintains-krystal-biotech-krys-buy-recommendation
-
Chardan Capital Maintains Krystal Biotech (KRYS) Buy Recommendation https://www.proinvestor.com/investornyt/989867/chardan-capital-maintains-krystal-biotech-krys-buy-recommendation
-
Guggenheim Maintains Krystal Biotech (KRYS) Buy Recommendation https://www.proinvestor.com/investornyt/989869/guggenheim-maintains-krystal-biotech-krys-buy-recommendation
-
Transcript fra Q&A med CEO Adam Steensberg fra Zealand Pharma d. 24. maj 2023 https://www.proinvestor.com/boards/112798
-
STENOCARE-PRODUKT ER GODKENDT OG KLAR TIL SALG I TYSKLAND https://www.proinvestor.com/boards/112800
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind